Evolving therapies in the treatment of hepatocellular carcinoma
Hans Christian Spangenberg, Robert Thimme, Hubert E BlumDepartment of Medicine II, University of Freiburg, D-79106 Freiburg, GermanyAbstract: Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well define...
Saved in:
Main Authors: | Hans Christian Spangenberg, Robert Thimme, Hubert E Blum |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2008
|
Subjects: | |
Online Access: | https://doaj.org/article/f20bb1efe6c84d029414f049c8bd3235 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic treatment for hepatocellular carcinoma
by: Manushi Aggarwal, et al.
Published: (2018) -
Sorafenib for the treatment of unresectable hepatocellular carcinoma
by: Junji Furuse
Published: (2008) -
Transcatheter Intra-Arterial Infusion Combined with Interventional Photothermal Therapy for the Treatment of Hepatocellular Carcinoma
by: Zhou J, et al.
Published: (2020) -
Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro
by: Jędrzak A, et al.
Published: (2020) -
Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
by: Zhou X, et al.
Published: (2012)